#ChooseOpenWebinar
LightNews LightNews
europepmc.org
Thanks for joining our "What happens when you choose closed?" webinar with @creativecommons.bsky.social and following along with #ChooseOpenWebinar! 🙌

Stay tuned for the recording and slides soon! 🎥

Following us for more on open licensing and research innovation!
#MedLib #PhDSky #OpenAccess
July 9, 2025 at 4:45 PM
europepmc.org
Want to stop AI training on your research?
Think a CC BY-NC-ND license will help?

Think again! @creativecommons.bsky.social says restrictive licenses don’t block AI training but do limit:

- rapid dissemination
- rigorous review
- equitable access

#ChooseOpenWebinar for updates 💡
#MedLib #PhDsky
July 9, 2025 at 4:42 PM
europepmc.org
Why should I make my research open?🤷
@creativecommons.bsky.social says:

CC BY lets you keep copyright whilst your work can be:
• Translated into other languages
• Adapted for education
• Used on Wikipedia

Open research = greater reach and impact! 🌍✨
#ChooseOpenWebinar for updates 💡
#MedLib #PhDsky
July 9, 2025 at 4:33 PM
europepmc.org
Aghhh, what licence should I choose?! 😩
@creativecommons.bsky.social make it simple:

CC BY is the least restrictive = maximises reuse & cuts legal hassle

CC BY lets others:
✅ Share your work
🔧 Adapt it

#OpenLicensing = more innovation 🚀

#ChooseOpenWebinar for updates 💡
#MedLib #PhDsky
July 9, 2025 at 4:27 PM
europepmc.org
Open licenses power discovery!

Melissa Harrison shares a @opentargets.org use case:

Open Targets identifies and prioritises drug targets using AI to extract gene, drug, and disease mentions and relationships to building drug development evidence

#ChooseOpenWebinar for updates 💡
#MedLib #PhDsky
July 9, 2025 at 4:16 PM
europepmc.org
Open licenses power discovery!

Melissa Harrison shares a @pfamdb.bsky.social use case:

Pfam uses AI to extract information about known protein domains

This helps predict protein function & identify potential drug targets! 💊

#ChooseOpenWebinar for live updates 💡
#MedLib #PhDsky #OpenAccess
July 9, 2025 at 4:11 PM
europepmc.org
Open licenses power discovery!

Melissa Harrison shares a @pride-ebi.bsky.social use case:

PRIDE the #proteomics database for large-scale protein studies uses AI to uncover associated proteomics data & link datasets across databases

#ChooseOpenWebinar for live updates 💡
#MedLib #PhDsky #OpenAccess
July 9, 2025 at 4:08 PM
europepmc.org
How does licensing affect innovation?

Melissa Harrison from @ebi.embl.org breaks it down with #EuropePMC stats:

• 10.8M full text = read only
• 7M full text = downloadable by XML
• 5.5M full text = open for reuse, including text-mining!

#ChooseOpenWebinar for live updates 💡
#MedLib #PhDsky
Licensing of articles in Europe PMC: 5.5 M CCO/CC-BY-SA/CC-BY Licenses for which free text available for derivative of commercial use. 7M open access full text which are free full text available as XML bulk download under a Creative Commons license, or similar. 10.8M free full text where the free full text in Europe PMC is read and display only. And 46.2M records where full text may be available elsewhere via Unpaywall integration.
July 9, 2025 at 3:55 PM
europepmc.org
Katherine Hughes on EMBL’s Open Science Policy:

EMBL's policy can serve as a model policy and an example of #OpenScience in practice

#ChooseOpenWebinar for live updates 💡
#MedLib #PhDsky
@embl.org @acraftylibrarian.bsky.social
EMBL's current Open Science Policy. 1. Deposit a preprint 2. Publish Open access with a CC BY license 3. Link publications to ORCIS during submission 4. Deposit in EPMC. 5. Standard EMBL affiliation acknowledgement.
July 9, 2025 at 3:42 PM
europepmc.org
🎓 Not all open licences are created equal!

Taylor Campbell from @creativecommons.bsky.social broke down key licence types👇

🔓 Most freedom: CC BY
⛔️ Least: CC BY-NC-ND

Your licence = your reuse rights. Choose wisely to boost impact & reach!

#ChooseOpenWebinar for live updates 💡
#MedLib #PhDsky
Image taken from Creative Commons slide dec in What happens when you choose closed? webinar 09July 2025. Creative Commons Licence Term Options Attribution (BY): Credit must be given to you, the creator. ShareAlike (SA): Adaptations must be shared under the same terms. NonCommercial (NC): Only noncommercial use of your work is permitted, not primarily intended for monetary compensation. NoDerivatives (ND): No derivatives or adaptations of your work are permitted. CCBY has the most freedoms followed by CC-BY-SA, CC-BY-NC, CC-BY-ND, and CC-BY-NC-ND as the least freedom
July 9, 2025 at 3:30 PM
europepmc.org
📢 What happens when you choose closed? - the webinar has started!

We’re diving into how licences shape research reuse, rights & reach including:

• CC BY & copyright
• AI & licensing
• Funder/journal requirements

Follow #ChooseOpenWebinar for live updates 💡
@creativecommons.bsky.social
July 9, 2025 at 3:24 PM